CIK 0001626878
- Non-accelerated filer
- Smaller reporting company
XBiotech Inc.
Sign in to watch- Ticker
- XBIT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 512-386-2900
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- Open-market buys, last 90 days
- $854,660
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$854,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-28 | SIMARD JOHN Chief Executive Officer | Other disposition · Stock Options | −89,260 | 110,740 | ||
| 2021-01-28 | SIMARD JOHN Chief Executive Officer | Other disposition · Stock Options | −150,000 | 150,000 | ||
| 2021-01-28 | SIMARD JOHN Chief Executive Officer | Other disposition · Stock Options | −500,000 | 500,000 | ||
| 2020-12-18 | BAY STREET FINANCIAL S.A. 10% owner | Sale | −1,173,033 | $18.78 | $22.0M | 1,981,515 |
| 2020-12-02 | BAY STREET FINANCIAL S.A. 10% owner | Sale | −182,836 | $18.42 | $3.4M | 3,154,548 |
| 2020-11-19 | MCKENZIE W THORPE Director | Sale | −375,000 | $18.30 | $6.9M | 2,560,964 |
| 2020-09-18 | SIMARD JOHN Chief Executive Officer | Other disposition | −500,000 | 3,723,166 | ||
| 2020-09-15 | SHIVASWAMY SUSHMA Chief Scientific Officer | Option exercise | +20,668 | $7.50 | $155K | 20,668 |
| 2020-09-15 | SHIVASWAMY SUSHMA Chief Scientific Officer | Sale | −20,668 | $20.00 | $413K | 0 |
| 2020-09-15 | SHIVASWAMY SUSHMA Chief Scientific Officer | Option exercise · Stock Options | −20,668 | 0 | ||
| 2020-09-10 | SHIVASWAMY SUSHMA Chief Scientific Officer | Option exercise | +19,332 | $7.50 | $145K | 19,332 |
| 2020-09-10 | SHIVASWAMY SUSHMA Chief Scientific Officer | Sale | −19,332 | $20.01 | $387K | 0 |
| 2020-09-10 | SHIVASWAMY SUSHMA Chief Scientific Officer | Option exercise · Stock options | −19,332 | 0 | ||
| 2020-09-01 | HAN QUEENA VP Finance & HR | Option exercise | +30,000 | $4.24 | $127K | 30,000 |
| 2020-09-01 | HAN QUEENA VP Finance & HR | Option exercise | +27,692 | $4.16 | $115K | 57,692 |
| 2020-09-01 | HAN QUEENA VP Finance & HR | Option exercise · Stock Option | −30,000 | 0 | ||
| 2020-09-01 | HAN QUEENA VP Finance & HR | Option exercise · Stock Option | −27,692 | 0 | ||
| 2020-08-27 | SIMARD JOHN Chief Executive Officer | Grant or award · Stock Options | +0 | 0 | ||
| 2020-08-27 | Libby Peter Director | Grant or award · Director Stock option | +25,000 | 25,000 | ||
| 2020-08-27 | Waldin Jan-Paul Director | Grant or award · Stock Option | +25,000 | 25,000 |
Page 4 of 14 · 273 trades